Signaling pathways
-
BA5092 NB001Summary: NB001 (HTS09836) is an adenylate cyclase 1 inhibitor. - BA5093 Mant-GTPγSSummary: Mant-GTPγS, a GTP mimetic, is a potent competitive adenylate cyclase inhibitor.
- BA5094 HeptaminolSummary: Heptaminol is a fatty amine with antihypertensive properties and is a potential antihypertensive agent.
- BA5097 NadololSummary: Nadolol (SQ-11725) is a non-selective orally active beta-adrenergic receptor blocker and a substrate for organic anion transporting polypeptide 1A2 (OATP1A2).
- BA5098 SalbutamolSummary: Salbutamol (Albuterol) is an orally active, short-acting beta2-adrenergic receptor agonist.
- BA5099 SalmeterolSummary: Salmeterol (GR33343X) is a potent selective human adrenergic receptor agonist.
- BA5100 YS-49Summary: YS-49 is an activator of (a downstream target of RhoA) and reduces RhoA/PTEN activation in 3-methylcholine-treated cells.
- BA5101 LabetalolSummary: Labetalol (AH5158) is an orally active selective α1- and non-selective β-adrenergic receptor competitive antagonist.
- BA5102 ClonidineSummary: Agonists.
- BA5103 ParoxetineSummary: Paroxetine, a phenylpiperidine derivative, is a potent selective serotonin reuptake inhibitor (SSRI).